1061 related articles for article (PubMed ID: 19160189)
21. Corticosteroids for the prevention and treatment of bronchopulmonary dysplasia: an overview of systematic reviews.
van de Loo M; van Kaam A; Offringa M; Doyle LW; Cooper C; Onland W
Cochrane Database Syst Rev; 2024 Apr; 4(4):CD013271. PubMed ID: 38597338
[TBL] [Abstract][Full Text] [Related]
22. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
Shah SS; Ohlsson A; Halliday HL; Shah VS
Cochrane Database Syst Rev; 2012 May; (5):CD002058. PubMed ID: 22592683
[TBL] [Abstract][Full Text] [Related]
23. Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
Shah V; Ohlsson A; Halliday HL; Dunn MS
Cochrane Database Syst Rev; 2007 Oct; (4):CD001969. PubMed ID: 17943764
[TBL] [Abstract][Full Text] [Related]
24. Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD001146. PubMed ID: 34674229
[TBL] [Abstract][Full Text] [Related]
25. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
Shah SS; Ohlsson A; Halliday HL; Shah VS
Cochrane Database Syst Rev; 2012 May; (5):CD002057. PubMed ID: 22592682
[TBL] [Abstract][Full Text] [Related]
26. Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
Shah V; Ohlsson A; Halliday HL; Dunn MS
Cochrane Database Syst Rev; 2000; (2):CD001969. PubMed ID: 10796275
[TBL] [Abstract][Full Text] [Related]
27. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
Shah SS; Ohlsson A; Halliday H; Shah VS
Cochrane Database Syst Rev; 2003; (1):CD002058. PubMed ID: 12535425
[TBL] [Abstract][Full Text] [Related]
28. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
Shah SS; Ohlsson A; Halliday H; Shah VS
Cochrane Database Syst Rev; 2003; (2):CD002057. PubMed ID: 12804423
[TBL] [Abstract][Full Text] [Related]
29. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.
Onland W; De Jaegere AP; Offringa M; van Kaam A
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010941. PubMed ID: 28141913
[TBL] [Abstract][Full Text] [Related]
30. Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants.
Henderson-Smart DJ; Bhuta T; Cools F; Offringa M
Cochrane Database Syst Rev; 2001; (3):CD000104. PubMed ID: 11686950
[TBL] [Abstract][Full Text] [Related]
31. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.
Onland W; van de Loo M; Offringa M; van Kaam A
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD010941. PubMed ID: 36912887
[TBL] [Abstract][Full Text] [Related]
32. Dexamethasone treatment after the first week of life for bronchopulmonary dysplasia in preterm infants: a systematic review.
Doyle LW; Ehrenkranz RA; Halliday HL
Neonatology; 2010; 98(4):289-96. PubMed ID: 20453523
[TBL] [Abstract][Full Text] [Related]
33. Late (≥ 7 days) inhaled corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
Onland W; Offringa M; van Kaam A
Cochrane Database Syst Rev; 2022 Dec; 12(12):CD002311. PubMed ID: 36521169
[TBL] [Abstract][Full Text] [Related]
34. Update on Postnatal Steroids.
Halliday HL
Neonatology; 2017; 111(4):415-422. PubMed ID: 28538237
[TBL] [Abstract][Full Text] [Related]
35. Inositol in preterm infants at risk for or having respiratory distress syndrome.
Howlett A; Ohlsson A; Plakkal N
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD000366. PubMed ID: 31283839
[TBL] [Abstract][Full Text] [Related]
36. Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants.
Shah SS; Ohlsson A; Halliday HL; Shah VS
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002057. PubMed ID: 29035425
[TBL] [Abstract][Full Text] [Related]
37. Systemic corticosteroids for the prevention of bronchopulmonary dysplasia, a network meta-analysis.
Hay S; Ovelman C; Zupancic JA; Doyle LW; Onland W; Konstantinidis M; Shah PS; Soll R
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD013730. PubMed ID: 37650547
[TBL] [Abstract][Full Text] [Related]
38. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome.
Abdel-Latif ME; Walker E; Osborn DA
Cochrane Database Syst Rev; 2024 Jan; 1(1):CD008309. PubMed ID: 38270182
[TBL] [Abstract][Full Text] [Related]
39. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.
Shah SS; Ohlsson A; Halliday HL; Shah VS
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002058. PubMed ID: 29041034
[TBL] [Abstract][Full Text] [Related]
40. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
Ohlsson A; Walia R; Shah S
Cochrane Database Syst Rev; 2008 Jan; (1):CD003481. PubMed ID: 18254020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
